VPC founder Claudio Gutierrez. Courtesy photo

Flexibility has always been a core component of Valens Project Consulting, but the unpredictable last year — as COVID-19 has ravaged the economy and oil industry, especially — has strengthened that vital skill even more.

"As the lockdown loomed and predictions of a closed economy foretold the massive loss of business, I was ready to hunker down and expect the loss of 100 percent of our customers," says VPC's owner and founder Claudio Gutierrez. "But by May, VPC had lost only a quarter of our customers, and by September we were down by just 50 percent — not nearly the disaster I had been prepared for."

Gutierrez understood that this situation was ultimately temporary, and when they were able to, these accounts would return as customers — with no hard feelings from his end.

Instead, VPC focused on what it could do to improve its own operations during the pandemic, and top of the list was growing the staff. Since the worst of the lockdown, VPC has expanded its permanent engineering resources in a variety of disciplines, including electrical engineer, process engineer, and reservoir engineer.

Its industries have expanded, too. VPC started out mainly in the engineering field, taking on project management, process improvement, cost reductions, and more on a contract basis.

Now, after a slight COVID delay, it has expanded its base of fabrication and industrial distribution companies to include those offering disaster relief (such as temporary emergency housing), automation companies, and construction companies.

VPC is even venturing into public projects, with a few in partnership with Harris County currently in the works.

Gutierrez also focused on the value of face-to-face meetings by traveling to seek out new markets, and now supports projects in Florida, Washington, and Louisiana. Next on the docket: expanding outside the U.S. and into Latin America.

But until these global plans can be realized, Valens Project Consulting has been organizing virtual activities and developing a podcast presence. You might have spotted them on LinkedIn, where Gutierrez's personal network has grown significantly and VPC has been adding followers daily.

The importance of in-person networking has not been lost on Gutierrez, however. He makes sure all precautions are in place for both his staff and clients, and that everyone's safety is top of mind.

"I've become an advocate for in-person meetings," he says. "I don't want virtual meetings to become 'the new normal.'"

---

Visit the website learn more about Valens Project Consulting or its offshoot, Potens Energy.

When time is money, speed is everything. Photo by chain45154/Getty Images

Houston entrepreneur explains how aiming small generates big growth even in trying times

Project by Project

Since founding Valens Project Consulting in 2017, Claudio Gutierrez has seen his business continue a steady climb upwards as smaller companies discover the benefit of having engineering assistance on retainer.

While large firms might have an entire department dedicated to engineering, project management, process improvement, and cost reduction, it is the medium-to-small companies looking to fill that gap on a case-by-case basis that are Gutierrez's bread and butter.

"I attribute our success to our business model," he says. "The companies we work with may not always need our services, but when they do, they need them yesterday."

A low-cost retainer-like structure means that — even better — those services have already been paid for. Larger companies can blow through their budgets quickly, but Valens' small, consistent price tag means they are always available and ready to begin the next project.

"It sounds counterintuitive to seek out smaller companies, but it works for us," he says.

The Valens Project Consulting team can also leap into action immediately with an incredibly quick response time.

"Being so flexible has been very valuable to us," Gutierrez says. "Some large oil and gas companies tend to move slowly, but when time is money, small businesses need that speed."

Valens is ensuring even quicker response times during this current uncertain environment caused by COVID-19, with constant communication and greater flexibility with payments. And now, in the midst of the worst oil crash in history, he understands how important it is to be able to support his company's customers with flexible payment terms and going above and beyond what's expected of engineering support.

"We're all wearing different hats at various times these days — it's a policy that our current customers appreciate," says Gutierrez.

It's understanding what these companies need, and when they need it, that is Gutierrez's special skill, in addition to something unique for his industry.

"For an engineer, I've been told I have people skills," he says. In fact, his warm demeanor and amiable personality work in tandem with other "soft skills" such as being trilingual and growing up global (he's originally from Nicaragua), having experienced different cultures all over the world.

Claudio GutierrezClaudio Gutierrez. Courtesy photo

Though Valens Project Consulting specializes mainly in the oil and gas industry, it has made inroads into food distribution and the medical field.

It's also expanding into a different vertical: the distribution of heavy industrial equipment. Potens Energy ("potens" means "power" in Latin, just as "valens" means "effective" or "strong") was recently formalized as a new company with Gutierrez's business partner, Danny Salinas, PhD.

"Diversification is key," says Gutierrez. "While the bulk of our business will always be energy and power generation, it doesn't hurt to explore necessary elements that all people need."

Claudio Gutierrez. Courtesy photo

Houston entrepreneur engineers support solutions for businesses

In the Lone Star State, size is often seen as a badge of honor — after all, "everything's bigger in Texas." However, small and medium-sized businesses are the bread and butter of Claudio Gutierrez's engineering consulting business, Valens Project Consulting.

Throughout his years as an engineer and manager at a variety of companies, Gutierrez noticed a gap.

"I found that smaller companies that didn't have a need for dedicated engineering departments occasionally did need help with engineering, project management, process improvement, cost reduction, and things of that nature," he says.

In 2017, Gutierrez decided to do something about it and officially launched Valens Project Consulting. The company specializes in helping small and medium-sized businesses grow their revenue by focusing on business efficiencies and strengthening an existing customer base.

Valens is a Latin word that translates to "effective" or "strong," and those are Gutierrez's goals for the companies with which he works.

Based in Houston since 2007, the Nicaraguan-born Gutierrez has worked at a variety of companies, ranging from an armored vehicle manufacturer to several cable management companies. At each company, Gutierrez's hard work was consistently rewarded with promotions and projects all over the world.

Throughout his years in the engineering world, Gutierrez honed his skills as a project manager and was also known for his great people skills. So he decided to combine his knack for sales with his engineering acumen and fill a void he'd begun noticing in the industry: that of reliable engineering staffing for companies that don't necessarily need an entire department.

Gutierrez started out as the sole employee of Valens Project Consulting, but now manages a growing staff of engineering professionals. The company has expanded its services from simply project management to include business development, lean manufacturing implementation, and more. They're currently in the initial phases of adding a new business vertical — industrial distribution — through which Valens Project Consulting will sell heavy equipment.

One factor that sets Valens Project Consulting apart is how nimble it is. A smaller staff, Gutierrez explains, can be "extremely flexible and have extremely fast reaction times." Valens Project Consulting achieves this through a combination of remote work and collaboration with other small companies.

"We understand our customers' intents and needs, and we're mindful of limited budgets, so we believe in fulfilling the spirit of the project, rather than being beholden to the letter of the project," says Gutierrez. "We can do this because we fully embrace technology that allows for remote work as much as possible, and by not being captive to a single, central location."

In addition to his contributions to Houston's business economy, Gutierrez is a staunch participant in and supporter of the arts. He has played classical piano for nearly three decades and used to be in a heavy metal band. Gutierrez is a huge fan of the Houston Symphony and is on the Houston Grand Opera board of trustees.

Gutierrez is both creative and analytical, and combines these two mindsets to create holistic business solutions for his clients.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”